Jill Vilaythong
Internal Medicine · San Antonio, TXNPI 1912107038
Payments from drug & device makers
Across 170 payments — averaging $16.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$341
- Pfizer$335
- AbbVie$234
- Almatica Pharma LLC$189
- Abbott$187
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$185
- plus $1K from 24 others
What the payments were for
- Food & beverage$2,842100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 22 | $341 |
| Pfizer | 25 | $335 |
| AbbVie | 13 | $234 |
| Almatica Pharma LLC | 10 | $189 |
| Abbott | 9 | $187 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 13 | $185 |
| Lilly USA, LLC | 8 | $134 |
| GSK | 8 | $131 |
| Daiichi Sankyo Inc. | 7 | $122 |
| Johnson & Johnson(2 entities) | 7 | $107 |
| Boehringer Ingelheim | 4 | $98 |
| Novartis | 5 | $93 |
| Merck | 5 | $82 |
| Astellas Pharma US Inc | 5 | $76 |
| Vivus LLC | 3 | $74 |
| Esperion Therapeutics, Inc. | 5 | $73 |
| Bausch Health US, LLC | 3 | $55 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $43 |
| Scilex Pharmaceuticals Inc. | 2 | $36 |
| Vertex | 1 | $35 |
| Inspire Medical Systems, Inc. | 2 | $33 |
| Millicent US Inc | 2 | $30 |
| Amgen | 2 | $29 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Bayer | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $16 |
| Nestle Healthcare Nutrition Inc. | 1 | $14 |
| IBSA Pharma Inc. | 1 | $12 |
How this compares
$2,842 in reported general payments places this provider in the 80th percentile of 7,675 internal medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 25 | $33,480 |
| RybelsusSemaglutide | 29 | $32,552 |
| MounjaroTirzepatide | 21 | $23,500 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 45 | $13,957 |
| SynthroidLevothyroxine Sodium | 42 | $4,435 |
| PaxlovidNirmatrelvir/Ritonavir | 18 | $2,858 |
| Boostrix TdapDiphth,pertuss(Acell),tet Vac | 25 | $1,775 |
| Rosuvastatin Calcium | 77 | $1,070 |
| Levothyroxine Sodium | 53 | $741 |
| Cefpodoxime Proxetil | 21 | $682 |
| Memantine Hcl | 14 | $536 |
| Azelastine Hcl | 13 | $536 |
| Gabapentin | 23 | $349 |
| Fluticasone Propionate | 12 | $267 |
| Omeprazole | 22 | $243 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $341 | $66,03354 claims |
| Lilly USA, LLCMounjaro | $134 | $23,50021 claims |
| GSKArexvy | $131 | $13,95745 claims |
| AbbVieSynthroid | $234 | $4,43542 claims |
| PfizerPaxlovid | $335 | $2,85818 claims |
| Almatica Pharma LLCSertraline Hcl | $189 | $10433 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,675 internal medicine providers in Texas.
Other internal medicine in San Antonio
- Robert BassSan Antonio$25.6M
- Hernan SalazarSan Antonio$18.5M
- Dennis RuffSan Antonio$7.5M
- Cassandra KeySan Antonio$5.6M
- Jan BurgerHouston$47.3M
- Nitin JainHouston$33.2M
- Muhammad IrfanTomball$30.6M
- Aung NaingHouston$30.6M
- Preetesh JainHouston$19.5M
- Paolo StratiHouston$19.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.